CoChat

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

Open access
Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., Watanabe, S. · 2005 · Alimentary Pharmacology & Therapeutics
Cited by 71

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Background : In functional gastrointestinal (GI) disorders including functional dyspepsia (FD) and irritable bowel syndrome (IBS), there might be no small extent of contributions of psychosomatic factors. As a therapy for IBS patients, the effectiveness of antidepressants has been reported. Aim : In this study, we evaluated the efficacy of H 2‐receptor antagonist (famotidine) and 5‐HT 4 receptor agonist (mosapride citrate). In addition, the effect of antidepressants was assessed as the second‐step therapy. Methods : Patients complaining upper GI symptoms were diagnosed as FD excluding organic diseases. Randomized patients received 20 mg/day of famotidine or 15 mg/day of mosapride citrate for 4 weeks and the efficacy was compared between the two groups based on a 10‐point visual analogue scale. When symptoms were not relieved (score improvement 0–2 points), patients received amitriptyline (30 mg/day) or no medication for 4 weeks randomly. Patients who had depression in psychological test (SDS) were omitted. Results : As the first‐step therapy, both famotidine and mosapride showed beneficial effects regardless of FD subtypes, age and gender. The efficacy of these two drugs in relieving FD symptoms was not significantly different. In patients who failed in the first‐step therapy, amitriptyline showed beneficial effects. Conclusions : These findings might be clinically important in view of the efficient relief of symptoms in FD patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02473.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 71

Metadata

Authors
Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., & Watanabe, S.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-06
Volume
21
Issue
s2
Pages
42-46
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2086872452
Cited by
71
References
6
FWCI
5.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02473.x
The paper
Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., & Watanabe, S. (2005). New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02473.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.